Show simple item record

dc.contributor.authorSabesan, Priyadharshini
dc.contributor.authorLankappa, Sudheer
dc.contributor.authorKhalifa, Najat
dc.contributor.authorKrishnan, Vasudevan
dc.contributor.authorGandhi, Rahul
dc.contributor.authorPalaniyappan, Lena
dc.date.accessioned2017-09-20T15:52:10Z
dc.date.available2017-09-20T15:52:10Z
dc.date.issued2015
dc.identifier.citationSabesan, P., Lankappa, S., Khalifa, N., Krishnan, V., Gandhi, R. & Palaniyappan, L. (2015). Transcranial magnetic stimulation for geriatric depression: Promises and pitfalls. World Journal Of Psychiatry, 5 (2), pp.170-181.
dc.identifier.other10.5498/wjp.v5.i2.170
dc.identifier.urihttp://hdl.handle.net/20.500.12904/8485
dc.descriptionCopyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
dc.description.abstractAs the global population gets older, depression in the elderly is emerging as an important health issue. A major challenge in treating geriatric depression is the lack of robust efficacy for many treatments that are of significant benefit to depressed working age adults. Repetitive transcranial magnetic stimulation (rTMS) is a novel physical treatment approach used mostly in working age adults with depression. Many TMS trials and clinics continue to exclude the elderly from treatment citing lack of evidence in this age group. In this review, we appraise the evidence regarding the safety and efficacy of rTMS in the elderly. A consistent observation supporting a high degree of tolerability and safety among the elderly patients emerged across the Randomised Controlled Trials and the uncontrolled trials. Further, there is no reliable evidence negating the utility of rTMS in the elderly with depression. We also identified several factors other than age that moderate the observed variations in the efficacy of rTMS in the elderly. These factors include but not limited to: (1) brain atrophy; (2) intensity and number of pulses (dose-response relationship); and (3) clinical profile of patients. On the basis of the current evidence, the practice of excluding elderly patients from TMS clinics and trials cannot be supported.;
dc.description.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473489/?ContensisTextOnly=true
dc.formatFull text uploaded
dc.subjectDepression
dc.subjectTranscranial magnetic stimulation
dc.titleTranscranial magnetic stimulation for geriatric depression: Promises and pitfalls
dc.typeArticle
refterms.dateFOA2021-06-14T10:14:05Z
html.description.abstractAs the global population gets older, depression in the elderly is emerging as an important health issue. A major challenge in treating geriatric depression is the lack of robust efficacy for many treatments that are of significant benefit to depressed working age adults. Repetitive transcranial magnetic stimulation (rTMS) is a novel physical treatment approach used mostly in working age adults with depression. Many TMS trials and clinics continue to exclude the elderly from treatment citing lack of evidence in this age group. In this review, we appraise the evidence regarding the safety and efficacy of rTMS in the elderly. A consistent observation supporting a high degree of tolerability and safety among the elderly patients emerged across the Randomised Controlled Trials and the uncontrolled trials. Further, there is no reliable evidence negating the utility of rTMS in the elderly with depression. We also identified several factors other than age that moderate the observed variations in the efficacy of rTMS in the elderly. These factors include but not limited to: (1) brain atrophy; (2) intensity and number of pulses (dose-response relationship); and (3) clinical profile of patients. On the basis of the current evidence, the practice of excluding elderly patients from TMS clinics and trials cannot be supported.;


Files in this item

Thumbnail
Name:
Sabesan 2015 170-181.pdf
Size:
1020.Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record